company
Hetero Labs Limited (Unit V)
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-04-29Hetero Labs Limited (Unit V) — Class II recall: Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx…
Frequently asked questions
- How many FDA warning letters has Hetero Labs Limited (Unit V) received?
- Argus HQ has not recorded an FDA warning letter for Hetero Labs Limited (Unit V) in our current dataset.
- What FDA recalls has Hetero Labs Limited (Unit V) issued?
- Argus HQ has recorded 1 FDA recall tied to Hetero Labs Limited (Unit V).
- Is Hetero Labs Limited (Unit V) FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for Hetero Labs Limited (Unit V). Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

